Functional Class and Physician-Perceived Severity are Similar in Treated and Untreated Patients with Pulmonary Arterial Hypertension: A Real-World Survey
Functional Class and Physician-Perceived Severity are Similar in Treated and Untreated Patients with Pulmonary Arterial Hypertension: A Real-World Survey
CHEST – October 2021
Now Enrolling: The PROSERA Phase 3 study of seralutinib in adults with Pulmonary Arterial Hypertension (PAH).
